6 terminated. 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Terminated 6 |
Follow Post-traumatic Stress Disorder: new trials by email Literature Review of Post-traumatic Stress Disorder trials Research Report on Post-traumatic Stress Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial of PRAX-114 in Participants With Post-Traumatic Stress Disorder 60 mg PRAX-114 or 40 mg PRAX-114, Placebo, 40 mg PRAX-114 - Post-traumatic Stress Disorder, Post Traumatic Stress Disorder | Phase 2 | Terminated | Praxis Precision Medicines | 11 | 2022-01-25 | 2022-12-01 |
| Pilot rTMS for AUD+mTBI repetitive transcranial magnetic stimulation - Alcohol Use Disorder, Mild Traumatic Brain Injury | Phase 2 | Terminated | VA Office of Research and Development | 2 | 2019-03-21 | 2026-10-30 |
| A Study To Assess the Effects Of PF-04457845 On BOLD fMRI In Subjects With Post Traumatic Stress Disorder PF-04457845, Placebo - Post-Traumatic Stress Disorder | Phase 2 | Terminated | Pfizer | 14 | 2014-10-01 | 2016-06-29 |
| Exercise: A Novel Treatment for Combat Post Traumatic Stress Disorder exercise training, Stretching training - Post-Traumatic Stress Disorder | Phase 2 | Terminated | INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium | 11 | 2011-10-01 | 2013-04-26 |
| Mission Connect Mild Traumatic Brain Injury (TBI) Integrated Clinical Protocol Atorvastatin, Placebo - Traumatic Brain Injury, Post-traumatic Stress Disorder | Phase 2 | Terminated | Baylor College of Medicine | 52 | 2010-02-01 | 2017-01-09 |
| Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD) paroxetine, placebo - Post-Traumatic Stress Disorder, Stress Disorders, Post-Traumatic | Phase 2 | Terminated | GlaxoSmithKline | 5 | 2008-01-25 | 2020-11-30 |
Stress Disorders, Post-Traumatic (6) · Brain Concussion (2) · Alcoholism (1) · Brain Injuries, Traumatic (1) · Combat Disorders (1) · Mental Disorders (1) · Post-Concussion Syndrome (1) · Stress Disorders, Traumatic (1) · Stress Disorders, Traumatic, Acute (1) · Trauma and Stressor Related Disorders (1)
Mental Disorders (5) · Stress Disorders, Traumatic (5) · Trauma and Stressor Related Disorders (5) · Brain Diseases (2) · Brain Injuries (2) · Central Nervous System Diseases (2) · Craniocerebral Trauma (2) · Head Injuries, Closed (2) · Nervous System Diseases (2) · Trauma, Nervous System (2) · Wounds and Injuries (2) · Wounds, Nonpenetrating (2) · Alcohol-Related Disorders (1) · Brain Injuries, Traumatic (1) · Chemically-Induced Disorders (1)
Atorvastatin (1) · Exercise (1) · N-pyridazin-3-yl-4-(3-((5-(trifluoromethyl)pyridin-2-yl)oxy)benzylidene)piperidine-1-carboxamide (1) · Paroxetine (1) · Transcranial Magnetic Stimulation (1)
Baylor College of Medicine (1) · GlaxoSmithKline (1) · INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium (1) · Pfizer (1) · Praxis Precision Medicines (1) · VA Office of Research and Development (1)
United States (5) · Japan (1)
Amy A Herrold, PhD BA (1) · Claudia S Robertson, MD (1) · Shawn D. Youngstedt, Ph.D. (1)
IK2RX000949 (1)